Additionally, subjects with NAFLD exhibit a defect in insulin suppression of free fatty acids (FFA), in keeping with insulin resistance at the level of the adipocyte [30]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.